Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Hüsnü Berk"'
Autor:
Focke Ziemssen, Thomas Hammer, Matthias Grueb, Bettina Mueller, Hüsnü Berk, Maria-Andreea Gamulescu, Jessica Voegeler, Joachim Wachtlin, OCEAN Study Group
Publikováno v:
Journal of Ophthalmology, Vol 2020 (2020)
Aim. The prospective, noninterventional OCEAN study assessed the safety of intravitreal ranibizumab injections for treatment of neovascular age-related macular degeneration, diabetic macular edema, and retinal vein occlusion under real-world conditio
Externí odkaz:
https://doaj.org/article/33f61bdfa5ae4da2b6c629aeb78ec942
Autor:
Steffen Schmitz-Valckenberg, Peter Wiedemann, Matus Rehak, Thomas Bertelmann, Gabriele E. Lang, Claudia Weiss, Nicolas Feltgen, Armin Wolf, Lars-Olof Hattenbach, Eva-Maria Paulus, Hüsnü Berk, Hans Hoerauf, Nicole Eter, Pankaj Puri, Amelie Pielen
Publikováno v:
American Journal of Ophthalmology. 169:258-267
To compare the efficacy and safety of the European labels of ranibizumab 0.5 mg vs dexamethasone 0.7 mg in patients with macular edema secondary to central retinal vein occlusion (CRVO).Phase IIIb, multicenter, double-masked, randomized clinical tria
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::448768900373bdfb47d4b44bcd152953
https://doi.org/10.1016/j.ajo.2016.04.020
https://doi.org/10.1016/j.ajo.2016.04.020
Autor:
Matus Rehak, Nicolas Feltgen, Uwe Rose, Gabriele E. Lang, Claudia Quiering, Steffen Schmitz-Valckenberg, Thomas Bertelmann, Armin Wolf, Josep Callizo, Hans Hoerauf, Lars-Olof Hattenbach, Nicole Eter, Amelie Pielen, Hüsnü Berk
Publikováno v:
Acta ophthalmologica. 96(8)
Purpose The COMRADE studies are the first randomized controlled head-to-head trials comparing the efficacy and safety of intravitreal ranibizumab versus dexamethasone (DEX) in patients with macular oedema secondary to retinal vein occlusion (RVO). Th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2cbe001af163351a96167ca417ee8081
https://pubmed.ncbi.nlm.nih.gov/29855153
https://pubmed.ncbi.nlm.nih.gov/29855153
Autor:
Thomas Bertelmann, Hüsnü Berk, Matus Rehak, Gabriele E. Lang, Lars-Olof Hattenbach, Eva-Maria Paulus, Stephen Taylor, Nicolas Feltgen, Claudia Weiss, Hans Hoerauf, Steffen Schmitz-Valckenberg, Armin Wolf, Nicole Eter, Amelie Pielen
Publikováno v:
Acta ophthalmologica. 96(1)
Purpose: To compare the efficacy and safety of ranibizumab 0.5 mg versus dexamethasone 0.7 mg according to their European labels in macular oedema secondary to branch retinal vein occlusion (BRVO) in a 6-month, phase IIIb, randomized trial. Methods:
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b64681e5b07b0812a9ac33e55ec8ef8d
https://pubmed.ncbi.nlm.nih.gov/28251811
https://pubmed.ncbi.nlm.nih.gov/28251811
Autor:
Hans Hoerauf, Nicolas Feltgen, Claudia Weiss, Eva-Maria Paulus, Steffen Schmitz-Valckenberg, Amelie Pielen, Pankaj Puri, Hüsnü Berk, Nicole Eter, Peter Wiedemann, Gabriele E. Lang, Matus Rehak, Armin Wolf, Thomas Bertelmann, Lars-Olof Hattenbach
Publikováno v:
American Journal of Ophthalmology. 169:292-293
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a6a390e74a71bf614ac9482ac6b111ee
https://doi.org/10.1016/j.ajo.2016.06.016
https://doi.org/10.1016/j.ajo.2016.06.016